1. Japan Stocks

  2. •

    Basic Materials

  3. •

    Chemicals
Shin-Etsu Chemical Co., Ltd.

Shin-Etsu Chemical Co., Ltd.

SHECF
Shin-Etsu Chemical Co., Ltd.US flagOther OTC
45.33
USD
-4.01
- -
84.17BMarket Cap
Shin-Etsu Chemical Co., Ltd.
SHECF
(Other OTC)

Recent

price

45.33

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
FRC
498.47
493.52
482.94
548.33
589.76
600.96
580.82
675.98
748.73
742.37
720.36
998.64
1,379.51
1,204.4
1,292.66
- -
611.21
Revenue per Share
47.16
47.41
49.79
53.44
60.41
69.89
82.57
124.86
145.2
151.03
141.35
240.76
347.84
259.41
269.52
- -
109.65
Basic EPS, GAAP
46.37
7.23
72.51
89.59
73.32
62.73
72.57
79.28
81.06
68.76
78.83
171.37
239.99
188.37
221.61
- -
- -
Free Cash Flow per Basic Share
20
20
20
19.99
20
21
22.99
25
35.07
42.04
43.99
58
95.95
105.35
103.32
- -
- -
Dividend per Share
704.41
732.52
748.58
781.03
820.27
868.93
928.11
1,027.13
1,128.79
1,218.35
1,316.4
1,498.35
1,684.41
1,815.27
1,955.55
- -
1,922.15
Book Value per Share
685.54
697.6
757.58
847.9
936.95
970.75
1,023.2
1,127.22
1,185.45
1,304.86
1,384.84
1,645.77
1,972.33
2,201.34
2,422.9
- -
2,432.3
Tangible Book Value per Share
2,123
2,123
2,123
2,126
2,129
2,130
2,130
2,132
2,129
2,079
2,078
2,077
2,036
2,005
1,981
1,878
1,994
Basic Weighted Avg Shares
1,058,257
1,047,731
1,025,409
1,165,819
1,255,543
1,279,807
1,237,405
1,441,432
1,594,036
1,543,525
1,496,906
2,074,428
2,808,824
2,414,937
2,561,249
- -
1,219,035
Sales/Revenue/Turnover
14.1
14.28
15.32
14.91
14.76
16.29
19.28
23.37
25.33
26.31
26.2
32.6
35.54
29.03
28.97
- -
26.18
Operating Margin (%)
93,732
82,868
80,961
91,445
96,918
100,466
93,087
112,016
137,570
131,172
143,807
168,788
213,632
227,619
238,357
- -
- -
Depreciation Expense
100,119
100,643
105,714
113,617
128,606
148,840
175,912
266,235
309,125
314,027
293,732
500,117
708,238
520,140
534,021
- -
218,701
Net Income, GAAP
27.27
35.01
34.59
36.42
34.4
31.65
26.36
20.64
24.4
25.29
25.6
24.58
25.15
28.97
29.79
- -
31.71
Effective Tax Rate (%)
9.46
9.61
10.31
9.75
10.24
11.63
14.22
18.47
19.39
20.34
19.62
24.11
25.21
21.54
20.85
- -
17.94
Profit Margin (%)
638,493
694,803
832,878
981,668
1,101,000
1,170,679
1,232,607
1,324,495
1,358,615
1,446,725
1,551,663
1,960,216
2,355,714
2,516,114
2,672,558
- -
2,697,856
Working Capital
5,548
1,454
7,709
7,557
7,116
5,288
1,578
8,430
7,624
15,124
15,986
16,940
18,812
13,913
7,452
- -
8,360
LT Debt
1,469,425
1,494,570
1,623,174
1,822,130
2,012,709
2,080,463
2,190,079
2,413,022
2,532,552
2,723,142
2,886,626
3,429,205
4,026,207
4,424,069
4,837,582
- -
4,886,185
Total Equity
7.19
6.38
6.45
6.29
6.19
6.81
8.06
11.31
12.02
11.27
10.14
15.71
19.52
11.52
11.01
- -
4.61
Return on Invested Capital (%)
6.52
6.41
6.41
6.7
7.23
7.92
8.77
12.18
12.83
12.15
10.58
15.66
19.08
12.81
12.37
- -
4.97
Return on Capital (%)
6.83
6.6
6.72
6.99
7.55
8.28
9.19
12.78
13.46
12.72
11.15
17.1
21.65
14.72
14.21
- -
5.87
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Mar'24
Jun'25
Sep'25
ST Debt
10,386
- -
11,485
LT Borrowings
13,913
- -
8,360
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
1,996
- -
1,980
Market Capitalization
13,233,701
12,194,163
11,433,037

Working Capital

FRC

•

in mil. unless spec.
Mar'24
Jun'25
Sep'25
Total Current Assets
3,036,509
- -
3,214,212
Cash, Cash Equivalents & STI
1,719,709
- -
1,821,142
Accounts Receivable, Net
481,812
- -
549,904
Inventories
720,645
- -
735,264
Total Current Liabilities
520,395
- -
516,356
Payables & Accruals
- -
- -
- -
ST Debt
10,386
- -
11,485
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
- -
Free Cash Flow
- -
- -
- -
Net Income, GAAP
- -
- -
- -
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
599,201
596,701
627,501
591,534
2,414,937
2025
- -
- -
- -
- -
2,561,249
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
76.13
- -
- -
- -
259.41
2025
- -
- -
- -
- -
269.52
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
105.35
2025
- -
- -
- -
- -
103.32
2026
- -
- -
- -
- -
- -
Similar Companies
Dongguang Chemical Limited (1702.HK)
DCM Shriram Industries Limited (DCMSRMIND.BO)
Foremost Clean Energy Ltd. (FMST)
Kazan Public Joint Stock Company Organichesky sintez (KZOS.ME)
Diamines and Chemicals Limited (DIAMINESQ.BO)
Chemplast Sanmar Limited (CHEMPLASTS.NS)
Business
Shin-Etsu Chemical Co., Ltd. manufactures and markets a broad portfolio of infrastructure materials, electronics materials, functional materials, and processing and specialized services; infrastructure materials include polyvinyl chloride resin, caustic soda, methanol, chloromethanes, and polyvinyl alcohol; electronics materials encompass semiconductor silicon, rare earth magnets, semiconductor encapsulating materials, LED packaging materials, photoresists, photomask blanks, and synthetic quartz products; functional materials comprise silicones, cellulose derivatives, silicon metal, synthetic pheromones, vinyl chloride-vinyl acetate copolymer, liquid fluoroelastomers, pellicles, and silicon anode material for lithium ion batteries; processing and specialized services cover processed plastics, export of technologies and plants, export and import of products, and engineering. The company, founded in 1926 and headquartered in Tokyo, Japan, operates globally with key facilities in the United States, Europe, China, Thailand, Malaysia, and other regions in Asia, serving industries such as construction, electronics, automotive, healthcare, and semiconductors. Recent developments include the decision in 2024 to make Mimasu Semiconductor Industry Co., Ltd. a wholly owned subsidiary through a tender offer, enhancing wafer product lines and supply chain stability; construction of a fourth manufacturing base for semiconductor lithography materials in Isesaki City, Gunma Prefecture, Japan; investments totaling 10 billion yen announced in 2025 for pharmaceutical cellulose business expansion at SE Tylose GmbH & Co. KG in Germany and the Naoetsu Plant in Japan, including a new L-HPC production facility and doubled storage capacity; and establishment of Shin-Etsu Silicone (Pinghu) Co., Ltd. in China for advanced silicone emulsions with completion targeted for 2026.